Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 300
- Registration Number
- NCT02624440
- Locations
- 🇩🇰
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Hematology, Rigshospitalet, Copenhagen, Denmark
🇩🇰Department of Hematology, Esbjerg Sygehus, Esbjerg, Denmark
Clarithromycin in Multiple Myeloma Induction Therapy
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2015-10-12
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 58
- Registration Number
- NCT02573935
- Locations
- 🇩🇰
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
🇩🇰Department of Hematology, Herlev Hospital, Herlev, Denmark
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 200
- Registration Number
- NCT02572492
- Locations
- 🇸🇪
Skåne University Hospital, Lund, Sweden
🇩🇰Aalborg University Hospital, Aalborg, Denmark
🇱🇹Vilnius University hospital "Santariskiu Clinics", Vilnius, Lithuania
Microdose Study of Melphalan, Bortezomib and Dexamethasone
Early Phase 1
- Conditions
- Interventions
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 6
- Registration Number
- NCT02109861
- Locations
- 🇩🇰
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
© Copyright 2024. All Rights Reserved by MedPath